EMILY HOFFMAN: Open Payments
NPI 1902411754 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 39 payments from 15 companies in 2025. Trend: 2023 $668 · 2024 $1,337 · 2025 $1,194
Food & beverage: $1,095Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 4 | $313 |
| Janssen Biotech, Inc. | 8 | $240 |
| Novartis Pharmaceuticals Corporation | 1 | $123 |
| ABBVIE INC. | 5 | $91 |
| UCB, Inc. | 3 | $77 |
| GENZYME CORPORATION | 3 | $67 |
| Amgen Inc. | 3 | $58 |
| Lilly USA, LLC | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $32 |
Products named: OPZELURA, TREMFYA, Rhapsido, DUPIXENT, Bimzelx, SKYRIZI, OTEZLA, TALTZ.
Industry payments across IA — which companies pay providers there.
